---
$id: https://graph.org.ai/products/commodity/51241246
$type: Product
source: UNSPSC
code: "51241246"
title: "Tacalcitol"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tacalcitol

**UNSPSC Code**: 51241246
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vitamin d analog with the molecular formula C27H44O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2W72OJ5ZU, chemically known as 1-alpha,24(r)-dihydroxyvitamin d3 but generally known as tacalcitol, which bears US NIH Compound Identifier 5282177. European Medicines Agency schedules Tacalcitol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10794MIG. The term TACALCITOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules tacalcitol in its Anatomical Therapeutic Chemical (ATC) Classification. TACALCITOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tacalcitol under HS 29061900 and SITC 51231. As of Q4 2014, TACALCITOL remains the US FDA Preferred Term for this commodity. Tacalcitol bears US NLM identifiers UMLS ID C0953467 and NCI Concept Code C87292. SMILES: OC(CCC(C1C2(C(CC1)/C(=C/C=C1\CC(O)CC(O)C1=C)CCC2)C)C)C(C)C.

